REGISTERED
on 02 Nov 2021
Last Applicant/ Owned by
Rue Des Professeurs Jeener et Brachet 12
B-6041 Gosselies
BE
Serial Number
79280749 filed on 15th Jan 2020
Registration Number
6541534 registered on 02th Nov 2021
Correspondent Address
Monte L. Falcoff/Jessica S. Sachs
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Suite 200
Troy, MI 48098
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
OXYGENE
Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79280749
Mark Type
No Service Mark
Attorney Docket Number
No 8674-200264
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th May 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| 15th May 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Apr 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| 21st Apr 2022 | FINAL DISPOSITION PROCESSED |
| 02th Feb 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 02th Nov 2021 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Aug 2021 | ASSIGNED TO EXAMINER |
| 17th Aug 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Aug 2021 | PUBLISHED FOR OPPOSITION |
| 14th Aug 2021 | NOTIFICATION PROCESSED BY IB |